Heterocyclic derivatives as histamine h in2- antagonists

Details Heterocyclic derivatives as histamine h in2- antagonists Heterocyclic derivatives as histamine h in2- antagonists

C - Chemistry, Metallurgy

07

D

260/255, 260/279

C07D 401/12 (2006.01) C07C 279/28 (2006.01) C07D 239/46 (2006.01) C07D 249/14 (2006.01) C07D 257/06 (2006.01) C07D 295/096 (2006.01) C07D 401/06 (2006.01) C07D 401/14 (2006.01) C07D 413/12 (2006.01) C07D 471/04 (2006.01)

Patent

CA 1192190

ABSTRACT OF THE DISCLOSURE The invention relates to compounds of the general formula (I) Image (I) and physiclogically acceptable salts, hydrates and bioprecursors thereof, in which R1 represents hydrogen, C1-14 alkyl, cycloalkyl, alkenyl, alkynyl, aralkyl, trifluoroalkyl, heteroaralkyl or alkyl substituted by cycloalkyl, hydroxy, alkoxy, amino, alkylamino or dialkylamino; and R2 represents hydrogen or C1-4 alkyl group; or R1 and R2 together with the nitrogen atom to which they are attached form a 5 to 10 membered ring which may be saturated or may contain at least one double bond, may be unsubstituted or may be substituted by one or more C1-3 alkyl groups or a hydroxy group and/or may contain another heteroatom selected from oxygen or sulphur; Alk represents a straight or branched alkylene chain of 1 to 3 carbon atoms; Q represents a benzene ring in which incorpor- ation into the rest of the molecule is through bonds at the 1- and 3- or 1- and 4- positions: R5 represents hydrogen or acyl; n and m, which may be the same or different, are each 1 or 2; Z represents one of the groups Image or ?NHR8 Abstract continued where X represents NCN, NSO2Methyl, NSO2Phenyl or CHNO2; R8 represents alkyl; R3 represents hydrogen, alkyl, alkenyl, aralkyl, hydroxy C2-6 alkyl, alkoxy C2-6 alkyl or C1-4 alkanoyl- oxy C2-6 alkyl; R7 represents hydrogen, alkyl, alkenyl, aralkyl, acyloxyalkyl, alkylthioalkyl, arylthioalkyl, aryloxy- alkyl, aralkyloxyalkyl, or the group (CH2)qR5 where q is zero, 1, 2, 3, 4, 5 or 6 and the alkylene chain (CH2)q may be straight or branched, and R6 is hydroxy, alkoxy, nitro, heteroaryl, tetra- hydropyranyloxy or CH2NHC(=X)NHR9 where X is as defined above, and R9 is alkyl; or R6 is the group NR10R11, where R10 is hydro- gen or alkyl; and R11 is hydrogen, alkyl, alkenyl, aryl, aralkyl, or heteroaralkyl, or R11 is the group SO2R12 where R12 is alkyl or aryl; or R11 is the group COR13 where R13 is hydrogen, alkyl, aryl, aralkyl, alkoxy, halomethyl, heteroaryl, heteroaralkyl or the group NHR14 where R14 is hydrogen, alkyl, cycloalkyl, aryl or aralkyl; or R10 and R11 together represent the group =CR15R16 where R15 represents aryl or heteroaryl and R16 represents hydrogen or alkyl; or R6 is the group SO2R17 in which R17 is hydroxy, alkyl, aryl or the group NR18R19 where R18 and R19, which may be the same or different, each represent hydrogen or alkyl; or R6 is the group COR20 where R20 is hydrogen, hydroxy, alkoxy, aryloxy, aralkyloxy, alkyl, aryl, aralkyl or the group NR21R22 where R21 is hydrogen or alkyl optionally substituted by a hydroxy or alkoxy group; and R22 is hydrogen, alkyl (optionally substituted Abstract continued by a hydroxy or alkoxy group), alkenyl, aryl, aralkyl or cycloalkyl, or NR21R22 forms a 5 to 8 membered ring which may contain another heteroatom, e.g. oxygen, or a double bond and/or may be substituted by hydroxy or one or two C1-3 alkyl groups; or R6 is the group CR23=NR24 where R23 is hydrogen, alkyl, aryl or aralkyl and R24 is hydroxy, alkoxy, aralkyloxy or -NHC(=Y)NH2 where Y is oxygen or sulphur; with the proviso that when the group R6 contains a carbon atom through which it is linked to the alkylene group (CH2)q then the total number of carbon atoms in the resulting chain is not greater than 6 (i.e. g is not greater than 5); R4 represents phenyl, phenoxy or pyridinyl which may optionally be substituted by one or more halogen, alkyl, alkoxyalkyl or alkoxy groups or by a methylene- dioxy group; p represents an integer which is 1, 2 or 3; the compounds show pharmacological activity as selective histamine H2-antagonists.

407940

Affiliated with

Also associated with

Rating

Heterocyclic derivatives as histamine h in2- antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic derivatives as histamine h in2- antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic derivatives as histamine h in2- antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1284431